• Multi-Omics Dissection of ARID1A-Driven Resistance in Melano

  2026-06-25

  This study presents a comprehensive multi-omics approach to uncover how ARID1A loss mediates resistance to BRAF/MAPK inhibitors in melanoma. By revealing specific signaling rewiring and immune evasion features, the work highlights actionable resistance nodes and deepens understanding of durable therapy challenges.

• Lipoamino Bundle LNPs: Spleen-Targeted mRNA Delivery Advance

  2026-06-25

  A recent study introduces lipoamino bundle lipid nanoparticles (LNPs) that achieve efficient mRNA transfection in dendritic cells and macrophages, with exceptional selectivity for spleen tissue. This approach enhances in vivo mRNA delivery and expression while addressing key challenges in targeting and innate immune activation.

• Dual-Reporter mRNA: Mechanisms, Strategy, and Translational

  2026-06-24

  This article provides a mechanistic and strategic deep dive into the use of EZ Cap™ Cy5 Firefly Luciferase mRNA (5-moUTP) for translational researchers. We explore the biological rationale behind its design, review experimental validations, compare next-generation mRNA delivery approaches, and offer actionable guidance for assay design and clinical translation—bridging recent advances in extrahepatic mRNA targeting with practical workflow optimization.

• Bacitracin (B1670): Technical Parameters for Laboratory Use

  2026-06-23

  Bacitracin (B1670) is a peptide antibiotic designed for controlled laboratory research targeting bacterial cell wall and peptidoglycan synthesis disruption. It is not suitable for diagnostic or medical use, and should be handled according to precise workflow and storage protocols to ensure reproducibility.

• Cy5.5 NHS Ester (Non-Sulfonated): Transforming In Vivo Fluor

  2026-06-23

  Explore how Cy5.5 NHS ester (non-sulfonated) advances in vivo fluorescence imaging with its superior near-infrared properties and stable amine-reactive labeling. This article delivers a unique, scientifically grounded perspective on optimizing biomolecule labeling and assay design.

• Tranexamic Acid: Antifibrinolytic Agent for Rapid Hemostasis

  2026-06-22

  Tranexamic Acid is a synthetic antifibrinolytic agent that inhibits plasminogen activation, stabilizing clots and reducing bleeding. It has demonstrated efficacy in both clinical and preclinical trauma models. APExBIO offers a high-purity Tranexamic Acid product (B1858) suited for research applications.

• Fluorescent mRNA Controls: Mechanistic Edge in Delivery Rese

  2026-06-22

  This article presents a thought-leadership perspective on how ARCA Cy5 EGFP mRNA (5-moUTP) advances translational research. It integrates mechanistic insight, experimental guidance, and strategic context for optimizing mRNA delivery and localization studies—bridging the latest in chemical modification and real-world assay design. Evidence from peer-reviewed studies and competitive benchmarking are woven throughout, culminating in a visionary outlook for the field.

• Applied Workflows with the Live-Dead Bacterial Staining Kit

  2026-06-21

  Harness the dual-fluorescent power of the Live-Dead Bacterial Staining Kit for precise, reproducible viability assays—even in challenging infection models. This guide unpacks experimental workflows, advanced troubleshooting, and translational insights inspired by recent nanomaterial-enabled research.

• miR-24-3p Regulates Sp1/PI3K Axis in Doxorubicin-Induced Hea

  2026-06-20

  New evidence demonstrates that miR-24-3p exacerbates doxorubicin-induced heart failure by directly suppressing the Sp1/PI3K signaling pathway. Silencing miR-24-3p confers protection against cardiomyocyte apoptosis and oxidative stress, highlighting a novel regulatory axis and potential therapeutic target for cardiac injury models.

• CCT007093: Selective PPM1D Inhibitor for P38 MAPK Pathway St

  2026-06-19

  CCT007093 is a potent, selective PPM1D inhibitor that activates the P38 MAPK pathway and demonstrates cell type-specific cytotoxicity. This compound is DMSO-soluble and widely used for dissecting PPM1D signaling in cancer and acute kidney injury models. Its mechanism and benchmarks are well-documented in peer-reviewed literature and product data.

• Cy5 amine (non-sulfonated): Technical Guide for Fluorescent

  2026-06-19

  Cy5 amine (non-sulfonated) addresses the need for a bright, photostable fluorophore in workflows requiring water-insoluble dyes for sensitive labeling of proteins, polymers, or nucleic acids. It is best suited for fluorescence microscopy and flow cytometry but is not appropriate for direct aqueous labeling or any clinical diagnostic applications.

• Dual Luciferase Reporter Gene System: Assay Design, Normaliz

  2026-06-18

  Explore the Dual Luciferase Reporter Gene System in-depth, focusing on assay normalization, mechanistic insights, and advanced protocol optimization. This article uniquely integrates reference findings and practical assay decisions for gene expression regulation studies.

• KR-12 (human) TFA: Reliable Antimicrobial Peptide for Lab Re

  2026-06-18

  This article presents an evidence-based, scenario-driven exploration of KR-12 (human) TFA (SKU C8754) as a robust tool for cell viability, antimicrobial, and immunomodulatory assays. Through real-world laboratory challenges, it demonstrates how KR-12's validated performance, non-cytotoxicity, and reproducibility—supported by published data—make it a reliable choice for biomedical researchers and technicians.

• Advancing mRNA Delivery: Mechanistic Insight and Strategic T

  2026-06-17

  This article bridges cutting-edge mechanistic understanding of mRNA delivery with actionable strategies for translational researchers, leveraging ARCA Cy5 EGFP mRNA (5-moUTP) to illuminate spatial and temporal dynamics in experimental and preclinical systems. It contextualizes the product within the evolving landscape of mRNA therapeutics, drawing on recent research and highlighting new experimental standards.

• Cy5-UTP: Advancing RNA Labeling & Mechanistic Insights in Tr

  2026-06-17

  Explore how Cy5-UTP (Cyanine 5-UTP) is transforming RNA probe synthesis and visualization, with deep mechanistic insight and actionable strategic guidance for translational researchers. This thought-leadership article draws from cutting-edge studies on lncRNA function in differentiation and competitive benchmarking to chart the future of fluorescent RNA labeling in high-impact molecular biology applications.

16375 records 1/1092 page Next 12345 下5页 Last page